We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$37.9M
2
BX icon
Blackstone
BX
+$16.9M
3
ABNB icon
Airbnb
ABNB
+$13.4M
4
KVUE icon
Kenvue
KVUE
+$10.4M
5
CIVI
Civitas Resources
CIVI
+$7.3M

Top Sells

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$125M
2
ACN icon
Accenture
ACN
+$57.6M
3
MDT icon
Medtronic
MDT
+$28M
4
AAPL icon
Apple
AAPL
+$21.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$19.3M

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IE icon
1801
Ivanhoe Electric
IE
$1.7B
$355K ﹤0.01%
29,840
– –
HOUS
1802
DELISTED
Anywhere Real Estate
HOUS
$355K ﹤0.01%
55,224
– –
DCOM icon
1803
Dime Commercial Bancshares
DCOM
$1.81B
$355K ﹤0.01%
17,770
– –
SRCE icon
1804
1st Source
SRCE
$2.13B
$354K ﹤0.01%
8,408
– –
SKWD icon
1805
Skyward Specialty Insurance
SKWD
$2.44B
$352K ﹤0.01%
12,863
+6,830
+113% +$170K
INSP icon
1806
Inspire Medical Systems
INSP
$1.68B
$351K ﹤0.01%
1,767
+1
+0.1% +$252
PTLO icon
1807
Portillo's
PTLO
$365M
$349K ﹤0.01%
22,691
– –
TMP icon
1808
Tompkins Financial
TMP
$1.44B
$349K ﹤0.01%
7,125
– –
CNOB icon
1809
Center Bancorp
CNOB
$1.81B
$349K ﹤0.01%
19,568
– –
ZM icon
1810
Zoom
ZM
$32.2B
$348K ﹤0.01%
4,978
+81
+2% +$5.62K
CTKB icon
1811
Cytek Biosciences
CTKB
$636M
$348K ﹤0.01%
62,982
– –
GDOT icon
1812
Green Dot
GDOT
$766M
$347K ﹤0.01%
24,929
– –
PCT icon
1813
PureCycle Technologies
PCT
$1.41B
$347K ﹤0.01%
61,852
– –
DCPH
1814
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$346K ﹤0.01%
27,220
– –
RYZ
1815
Ryerson Holding Corp
RYZ
$1.5B
$346K ﹤0.01%
11,895
– –
ARKO icon
1816
ARKO Corp
ARKO
$505M
$345K ﹤0.01%
48,267
– –
GDYN icon
1817
Grid Dynamics Holdings
GDYN
$644M
$344K ﹤0.01%
28,241
– –
TVTX icon
1818
Travere Therapeutics
TVTX
$5.79B
$344K ﹤0.01%
38,438
– –
CTEV
1819
Claritev Corp
CTEV
$599M
$343K ﹤0.01%
5,110
– –
KRTX
1820
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$343K ﹤0.01%
2,028
– –
VRDN icon
1821
Viridian Therapeutics
VRDN
$2.49B
$342K ﹤0.01%
22,271
– –
IJH icon
1822
iShares Core S&P Mid-Cap ETF
IJH
$128B
$342K ﹤0.01%
6,850
-120,500
-95% -$6.31M
KE
1823
Kimball Electronics
KE
$606M
$341K ﹤0.01%
12,443
– –
KURA icon
1824
Kura Oncology
KURA
$896M
$340K ﹤0.01%
37,332
+1,436
+4% +$14.6K
EDIT icon
1825
Editas Medicine
EDIT
$432M
$340K ﹤0.01%
43,591
+6,443
+17% +$55.3K
71 72
73
74 75

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.